From what 5 stock analysts predict, the share price for Surgery Partners Inc (SGRY) might increase by 21.47% in the next year. This is based on a 12-month average estimation for SGRY. Price targets go from $35.00 to $50.00. The majority of stock analysts believe SGRY is a buy. Please note analyst price targets are not guaranteed and could be missed completely.
SGRY is a stock in Health Care which has been forecasted to be worth $42.60 as an average. On the higher end, the forecast price is $50.00 USD by kevin fischbeck from Bank of America Securities and on the lower end SGRY is forecasted to be $35.00 by gary taylor from TD Cowen.
Analyst/Firm |
Rating |
Price Target |
Change |
Date |
---|---|---|---|---|
lisa gill J.P. Morgan | Hold | $38.0 | maintained | Dec 13, 2023 |
chad vanacore Stifel Nicolaus | Hold | $12.0 | maintained | May 8, 2019 |
john ransom Raymond James | Hold | None | maintained | Aug 9, 2018 |
joshua raskin Nephron | Hold | $20.0 | reiterated | Aug 10, 2016 |
andrew schenker Morgan Stanley | Hold | $22.0 | reiterated | May 6, 2016 |
In 2023, SGRY generated $0 in revenue, which was a increase of 0.00% from the previous year. This can be seen as a signal that SGRY's business is growing, and its share price could be worth more in the future. However, if the company grows faster (or slower) than expected, this could also have a major impact on the future share price.
Revenue From 2019
Revenue From 2020
Revenue From 2021
Revenue From 2022
SOFI-USD
$8.33
TMUS-USD
$161.76
TXN-USD
$162.4
UPST-USD
$33.9
$27.88
TXG-USD
$49.11